Palvella Therapeutics (PVLA) Other Working Capital Changes (2014 - 2026)
Palvella Therapeutics (PVLA) reported Other Working Capital Changes of $357000.0 for Q1 2026, up 260.81% quarter-over-quarter from -$222000.0 in Q4 2025.
Palvella Therapeutics (PVLA) Other Working Capital Changes (2014 - 2026) Analysis & Trends
Palvella Therapeutics (PVLA) has 13 years of Other Working Capital Changes data on file, last reported at $357000.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $357000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.0 million (down 164.68% YoY), and the FY2025 annual result was -$1.4 million, down 190.75% from the prior year.
- Other Working Capital Changes climbed to $357000.0 in Q1 2026 per PVLA's latest filing, from -$222000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $19.7 million in Q1 2022 and troughed at -$34.1 million in Q4 2023.
- A 5-year average of $75812.5 and a median of $148500.0 in 2024 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes surged 3341.02% in 2023, then sank 688.96% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at -$26.4 million in 2022, then declined by 29.08% to -$34.1 million in 2023, then surged by 103.7% to $1.3 million in 2024, then tumbled by 117.62% to -$222000.0 in 2025, then surged by 260.81% to $357000.0 in 2026.
- Business Quant data shows PVLA's Other Working Capital Changes at $357000.0 in Q1 2026, -$222000.0 in Q4 2025, and -$182000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Palvella Therapeutics | 1.49 Bn | 1.23 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 357,000.00 |
| Mar 31, 2026 | 357,000.00 |
| Dec 31, 2025 | -222,000.00 |
| Dec 31, 2025 | -222,000.00 |
| Sep 30, 2025 | -182,000.00 |
| Sep 30, 2025 | -182,000.00 |
| Jun 30, 2025 | -960,000.00 |
| Jun 30, 2025 | -960,000.00 |
| Dec 31, 2024 | 1.26 Mn |
| Dec 31, 2024 | 1.26 Mn |
| Sep 30, 2024 | 134,000.00 |
| Sep 30, 2024 | 134,000.00 |
| Jun 30, 2024 | 163,000.00 |
| Jun 30, 2024 | 163,000.00 |
| Mar 31, 2024 | -54,000.00 |
| Mar 31, 2024 | -54,000.00 |
| Dec 31, 2023 | -34.08 Mn |
| Dec 31, 2023 | -34.08 Mn |
| Sep 30, 2023 | 15.52 Mn |
| Sep 30, 2023 | 15.52 Mn |